Carlyle Puts Up $4B For J&J's Blood-Testing Unit

Law360, New York (January 16, 2014, 12:48 PM EST) -- Private equity powerhouse The Carlyle Group LP announced Thursday that it will acquire Johnson & Johnson's blood-testing diagnostics unit, Ortho-Clinical Diagnostics Inc., for $4.15 billion.

Raritan, N.J.-based Ortho-Clinical Diagnostics manufactures blood-testing tools and equipment for hospitals, laboratories and blood centers worldwide. Carlyle said it plans to operate OCD as a stand-alone business after the transaction is finalized. OCD operates in 130 countries and maintains its manufacturing operations in Rochester, N.Y.; Pompano Beach, Fla.; and Pencoed, Wales.

Carlyle said that equity for the transaction comes from Carlyle...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.